The objective of this study was to evaluate the effect of feeding maternal colostrum (MC), a plasma-derived (PDCR) or colostrum-derived colostrum replacer (CDCR) on passive transfer of immunity, health, and performance of preweaning heifer calves. Preplanned contrasts were performed for MC versus CR (PDCR combined with CDCR) and PDCR versus CDCR. At birth, calves were randomly assigned to 1 of 3 treatment groups: MC (n=49), 3.8L of maternal colostrum; PDCR (n=49), 550 g (1 dose; 150 g of IgG) of a PDCR; or CDCR (n=49), 470 g (1 dose; 100g IgG) of a CDCR. The best total protein cutoff for determining passive transfer was >5.2, 5.6, and 5.1g/dL for MC, PDCR, and CDCR, respectively. Serum total protein was greater for calves fed MC (mean ± SE; 6.14 ± 0.11 g/dL) than for calves fed PDCR (5.29 ± 0.11 g/dL) and CDCR (5.27 ± 0.11 g/dL). Serum IgG concentrations were greater for calves fed MC (2,098 ± 108 g/dL) than for calves fed PDCR (927 ± 107 g/dL) or CDCR (1,139 ± 108 g/dL). Apparent efficiency of absorption was greater for CDCR than PDCR (38.8 ± 3.0 vs. 21.6 ± 3.0%). Adequate passive transfer was greatest for MC (91.8%), followed by CDCR (49%) and PDCR (28.6%). Calves fed MC had greater weaning weights and body weight gain than calves fed CR. Morbidity was lower for calves fed MC (46.9%) than for calves fed PDCR (71.4%) or CDCR (67.3%). Calves fed MC tended to have lower mortality than calves fed CR. Given the conditions of this trial, feeding 3.8L of MC was superior to feeding one dose of CR. Further research is needed to evaluate calf performance when a higher dose of CR is fed.

A 5-yr follow-up of an arthritis education programme is reported. After adjustment for those lost, deceased or moved away, the 5-yr response rate was 75% among intervention subjects and 78% among controls. Individuals who participated in the education programme maintained their increased knowledge in some aspects. The relative difference in pain and disability over 5 yr was greater in the control group. Most individuals were less active at practising exercise after 5 yr. Improvement in performing exercise and joint protection shown at 12-months follow-up did not persist. Additional questions after 5 yr showed that participants in the education programme had significantly more contact with rheumatologists, physiotherapists and occupational therapists. The participants developed an increased internal sense of control of the disease between 12 months and 5 yr. There was also a significant reduction in reported problems with their disease after 12 months, maintained after 5 yr. This may indicate that patient education contributes to the patient's feeling of responsibility for, and ability to cope with, their diseases.

No abstract